Chronic kidney disease and cardiac morbidity — What are the possible links?

Michael Freundlich, Steven E Lipshultz, Guido Filler

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

It is increasingly clear that the long-term outcome of children with chronic kidney disease (CKD) is associated with their cardiovascular outcomes. Renal dysfunction affects cardiovascular outcomes, and cardiovascular dysfunction affects renal outcomes. Despite many publications about cardio-renal syndrome (CRS) types I to III (acute CRS, chronic CRS and acute renocardiac syndrome), the literature about type IV CRS (chronic renocardiac syndrome) remains scant. Here, we summarize the pathophysiological risk factors of cardiovascular comorbidity and CKD. We address the exceedingly high prevalence of cardiovascular morbidity and mortality in children and adolescents with CKD and their risk factors for cardiovascular disease (CVD). Of these risk factors, uremia, renal osteodystrophy, vitamin D pathophysiology, and Fibroblast Growth Factor 23 (FGF23)-related direct effects on the myocardium and the large vessels appear to be the most prominent. We identify potential targets for intervention and highlight the need for a multidisciplinary approach involving both pediatric cardiologists and nephrologists.

Original languageEnglish (US)
Pages (from-to)89-95
Number of pages7
JournalProgress in Pediatric Cardiology
Volume41
DOIs
StatePublished - Jun 1 2016

Fingerprint

Cardio-Renal Syndrome
Chronic Renal Insufficiency
Morbidity
Chronic Kidney Disease-Mineral and Bone Disorder
Kidney
Child Mortality
Uremia
Vitamin D
Publications
Comorbidity
Myocardium
Cardiovascular Diseases
Pediatrics

Keywords

  • Cardiac Hypertrophy
  • Chronic Kidney Disease
  • Fibroblast Growth Factor 23
  • Uremia
  • Vitamin D

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Chronic kidney disease and cardiac morbidity — What are the possible links? / Freundlich, Michael; Lipshultz, Steven E; Filler, Guido.

In: Progress in Pediatric Cardiology, Vol. 41, 01.06.2016, p. 89-95.

Research output: Contribution to journalReview article

@article{09758b90bba643e190c649af0f2c1636,
title = "Chronic kidney disease and cardiac morbidity — What are the possible links?",
abstract = "It is increasingly clear that the long-term outcome of children with chronic kidney disease (CKD) is associated with their cardiovascular outcomes. Renal dysfunction affects cardiovascular outcomes, and cardiovascular dysfunction affects renal outcomes. Despite many publications about cardio-renal syndrome (CRS) types I to III (acute CRS, chronic CRS and acute renocardiac syndrome), the literature about type IV CRS (chronic renocardiac syndrome) remains scant. Here, we summarize the pathophysiological risk factors of cardiovascular comorbidity and CKD. We address the exceedingly high prevalence of cardiovascular morbidity and mortality in children and adolescents with CKD and their risk factors for cardiovascular disease (CVD). Of these risk factors, uremia, renal osteodystrophy, vitamin D pathophysiology, and Fibroblast Growth Factor 23 (FGF23)-related direct effects on the myocardium and the large vessels appear to be the most prominent. We identify potential targets for intervention and highlight the need for a multidisciplinary approach involving both pediatric cardiologists and nephrologists.",
keywords = "Cardiac Hypertrophy, Chronic Kidney Disease, Fibroblast Growth Factor 23, Uremia, Vitamin D",
author = "Michael Freundlich and Lipshultz, {Steven E} and Guido Filler",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.ppedcard.2015.11.001",
language = "English (US)",
volume = "41",
pages = "89--95",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Chronic kidney disease and cardiac morbidity — What are the possible links?

AU - Freundlich, Michael

AU - Lipshultz, Steven E

AU - Filler, Guido

PY - 2016/6/1

Y1 - 2016/6/1

N2 - It is increasingly clear that the long-term outcome of children with chronic kidney disease (CKD) is associated with their cardiovascular outcomes. Renal dysfunction affects cardiovascular outcomes, and cardiovascular dysfunction affects renal outcomes. Despite many publications about cardio-renal syndrome (CRS) types I to III (acute CRS, chronic CRS and acute renocardiac syndrome), the literature about type IV CRS (chronic renocardiac syndrome) remains scant. Here, we summarize the pathophysiological risk factors of cardiovascular comorbidity and CKD. We address the exceedingly high prevalence of cardiovascular morbidity and mortality in children and adolescents with CKD and their risk factors for cardiovascular disease (CVD). Of these risk factors, uremia, renal osteodystrophy, vitamin D pathophysiology, and Fibroblast Growth Factor 23 (FGF23)-related direct effects on the myocardium and the large vessels appear to be the most prominent. We identify potential targets for intervention and highlight the need for a multidisciplinary approach involving both pediatric cardiologists and nephrologists.

AB - It is increasingly clear that the long-term outcome of children with chronic kidney disease (CKD) is associated with their cardiovascular outcomes. Renal dysfunction affects cardiovascular outcomes, and cardiovascular dysfunction affects renal outcomes. Despite many publications about cardio-renal syndrome (CRS) types I to III (acute CRS, chronic CRS and acute renocardiac syndrome), the literature about type IV CRS (chronic renocardiac syndrome) remains scant. Here, we summarize the pathophysiological risk factors of cardiovascular comorbidity and CKD. We address the exceedingly high prevalence of cardiovascular morbidity and mortality in children and adolescents with CKD and their risk factors for cardiovascular disease (CVD). Of these risk factors, uremia, renal osteodystrophy, vitamin D pathophysiology, and Fibroblast Growth Factor 23 (FGF23)-related direct effects on the myocardium and the large vessels appear to be the most prominent. We identify potential targets for intervention and highlight the need for a multidisciplinary approach involving both pediatric cardiologists and nephrologists.

KW - Cardiac Hypertrophy

KW - Chronic Kidney Disease

KW - Fibroblast Growth Factor 23

KW - Uremia

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84977610670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977610670&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2015.11.001

DO - 10.1016/j.ppedcard.2015.11.001

M3 - Review article

AN - SCOPUS:84977610670

VL - 41

SP - 89

EP - 95

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

ER -